Moducare treatment versus watchful waiting for mild cervical changes
Part of Women’s health & pregnancy clinical trials.
This study tests a treatment called MODUCARE for CIN 1, a mild cervical change that sometimes goes away without treatment. The treatment is compared to just waiting and monitoring. The goal is to see if MODUCARE helps clear the abnormality faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with CIN 1, a mild cervical abnormality that often resolves on its own.
- You are between 18 and 85 years old.
- You are generally healthy and able to carry out daily activities (ECOG performance status 0-1).
- You are not pregnant.
- You have not had surgery on your cervix before.
- You have no history of cancer in your pelvic area.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks whether “therapy abstention” (not treating right away) and close monitoring is safe for certain high-grade cervical cell changes. It may help some people avoid immediate procedures while still catching any progression early.
This trial studies a “conservative” (less immediate) approach to a specific abnormal cervix finding to see if it can be managed safely for people who want future pregnancies. It uses close follow-up visits instead of immediate procedures for certain results.
This study tests a new tool called PreCursor-M+® to see how well it helps doctors manage CIN2, a moderate cervical cell change. It’s for people who have already been diagnosed with CIN2 and know their HPV test results.
This study tests whether a vaginal gel can help early cervical cell changes (CIN1 or CIN2) go away on their own and clear the HPV virus. If you are being monitored without treatment, this gel might increase your chances of recovery.
This study tests whether honey applied directly to the cervix can help reverse moderate cervical cell changes (CIN II). It may offer a natural alternative to more invasive procedures.
This study looks for ways to predict who will respond to imiquimod cream for precancerous cervical cell changes (CIN2 or CIN3). Results may help doctors choose the best treatment approach and better plan follow-up.
Hear when a new Low-grade Cervical Intraepithelial Neoplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.